Xywav, Jzp258
Narcolepsy, Idiopathic Hypersomnia
Phase III
Recruiting
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
May 27, 2026
―
Carboplatin, Paclitaxel, Docetaxel, Zanidatamab, Trastuzumab, Pertuzumab
Breast Cancer, Her2-Positive Breast Cancer
Phase II
Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Jul 28, 2025
―
Jzp441
Narcolepsy
Phase I
Recruiting
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
Apr 29, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Jazz Pharmaceuticals (JAZZN) have in its pipeline
JAZZN is currently developing the following drugs: Cannabidiol Oral Solution, Epidiolex, Cbd-Os, Jzp926 Capsule, Cbd-Os. These drug candidates are in various stages of clinical development as the company works toward FDA approval.